中文

News

News

InhalPharma Completes Nearly 100 Million RMB Series B Financing! Accelerating DP

Recently, InhalPharma announced the completion of a nearly 100 million RMB Series B financing round. This round was led by the Beijing Medical Health Industry Investment Fund, with participation from investors including Sanze Ventures.

Inhal Pharma Completed 50 million Yuan in Round A Financing

Suzhou Inhal Pharma Co., Ltd., a leading domestic innovative dry powder inhalation (DPI) company, successfully completed round A financing, raising more than 50-million-yuan RMB (about US $6.8 mn) in funds.

Academician Zhu Jingxu, Visited Kelun Pharmaceutical Research Institute

Academician Zhu led the InhalPharma delegation to visit Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. in Chengdu, and received warm welcome from the institute officials.
Ningbo Inhal Medical Devices Co., Ltd. Obtains ISO 13485 Medical Device R&D 2025-12-08 On November 17, 2025, after rigorous audits and professional evaluation, Ningbo Inhal Medical Devices Co., Ltd. successfully obtained the Medical Device Quality Management System Certification. This milestone not only signifies that the company’s R&D
View details
InhalPharma Released the Self-Developed Reservoir Type DPI 2022-08-01 InhalPharma, as the sponsor of 13th CIS-ASIA, released the self-developed Reservoir Type Dry Powder Inhalation device for the first time in the "Inhalation Development" forum.
View details
Prof Zhu Jingxu was Awarded the AIChE PTF Award for Lifetime Achievements 2021-11-25 Prof Zhu was awarded the Elsevier Particle Technology Forum Award for Lifetime Achievements. This award is judged by Particle Technology Forum(PTF), American Institute of Chemical Engineers.
View details
Prof Zhu Delivered an Academic Presentation at Chinese Pharmaceutical University 2021-11-12 Prof Zhu brought a seminar entitled "Microparticles Technology Boosts Medical Innovation" to the teachers and students of Chinese Pharmaceutical University(CPU).
View details
Inhal Pharma was Approved to Establish an Academician Workstation! 2021-09-24 With the approval of the Ningbo Science and Technology Association, "Ningbo Inhal Pharma Co., Ltd. Academician Workstation" was successfully established. The establishment of the Academician Workstation will better promote Inhal Pharma to cultiv
View details
Inhal Pharma Suzhou R&D Center Officially Launched! 2021-09-17 On September 5, 2021, under the witness of all the leaders, Ningbo Inhal Pharma Co., Ltd. officially opened its Suzhou R&D Center in Suzhou Institute of Pharmaceutical Innovation, Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
View details
首页上页12下页尾页
  • 波浪
  • 波浪
  • 波浪
  • 波浪
+86 (512) 6799-5502
yyy@inhalpharma.com
Ms. Yao
218 Xinghu Road
Room 202, 2F, Bldg B12
SIP, Suzhou, JS 215125
P. R. CHINA

© 2020-2026 Suzhou Inhal Pharma Co., Ltd. All rights reserved